Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape - PubMed (original) (raw)
Review
Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape
A K Sewell et al. Stem Cells. 2000.
Abstract
Effective preventive and therapeutic intervention in individuals exposed to or infected with human immunodeficiency virus (HIV) depends, in part, on a clear understanding of the interactions between the virus and those elements of the host immune response which control viral replication. Recent advances have provided compelling evidence that cytotoxic T lymphocytes (CTLs) constitute an essential component of protective antiretroviral immunity. Here, we review briefly the significance of this work in the context of previous studies, and outline the mechanisms through which HIV evades CTL activity.
Similar articles
- Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
Price DA, O'callaghan CA, Whelan JA, Easterbrook PJ, Phillips RE. Price DA, et al. Clin Sci (Lond). 1999 Dec;97(6):707-18. Clin Sci (Lond). 1999. PMID: 10585898 Review. - Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
Kent SJ, Fernandez CS, Dale CJ, Davenport MP. Kent SJ, et al. Trends Microbiol. 2005 Jun;13(6):243-6. doi: 10.1016/j.tim.2005.03.011. Trends Microbiol. 2005. PMID: 15936652 Review. - Anti-HIV adaptive immunity: determinants for viral persistence.
Yamamoto H, Matano T. Yamamoto H, et al. Rev Med Virol. 2008 Sep-Oct;18(5):293-303. doi: 10.1002/rmv.577. Rev Med Virol. 2008. PMID: 18416450 Review. - Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA.
Kumar A, Buch S, Foresman L, Bischofberger N, Lifson JD, Narayan O. Kumar A, et al. Virology. 2001 Jan 5;279(1):97-108. doi: 10.1006/viro.2000.0710. Virology. 2001. PMID: 11145893 - The role of CD8+ T-cell response in HIV infection.
Benito JM, López M, Soriano V. Benito JM, et al. AIDS Rev. 2004 Apr-Jun;6(2):79-88. AIDS Rev. 2004. PMID: 15332430 Review.
Cited by
- Role of T cell death in maintaining immune tolerance during persistent viral hepatitis.
Larrubia JR, Lokhande MU, García-Garzón S, Miquel J, Subirá D, Sanz-de-Villalobos E. Larrubia JR, et al. World J Gastroenterol. 2013 Mar 28;19(12):1877-89. doi: 10.3748/wjg.v19.i12.1877. World J Gastroenterol. 2013. PMID: 23569333 Free PMC article. Review. - High viral fitness during acute HIV-1 infection.
Arnott A, Jardine D, Wilson K, Gorry PR, Merlin K, Grey P, Law MG, Dax EM, Kelleher AD, Smith DE, McPhee DA; Pulse Study Team. Arnott A, et al. PLoS One. 2010 Sep 9;5(9):e12631. doi: 10.1371/journal.pone.0012631. PLoS One. 2010. PMID: 20844589 Free PMC article. - Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication.
Mothé BR, Weinfurter J, Wang C, Rehrauer W, Wilson N, Allen TM, Allison DB, Watkins DI. Mothé BR, et al. J Virol. 2003 Feb;77(4):2736-40. doi: 10.1128/jvi.77.4.2736-2740.2003. J Virol. 2003. PMID: 12552014 Free PMC article. - Gain and loss of T cell subsets in old age--age-related reshaping of the T cell repertoire.
Arnold CR, Wolf J, Brunner S, Herndler-Brandstetter D, Grubeck-Loebenstein B. Arnold CR, et al. J Clin Immunol. 2011 Apr;31(2):137-46. doi: 10.1007/s10875-010-9499-x. Epub 2011 Jan 18. J Clin Immunol. 2011. PMID: 21243520 Review. - Engineering T Cells to Functionally Cure HIV-1 Infection.
Leibman RS, Riley JL. Leibman RS, et al. Mol Ther. 2015 Jul;23(7):1149-1159. doi: 10.1038/mt.2015.70. Epub 2015 Apr 21. Mol Ther. 2015. PMID: 25896251 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical